2023 Was a tricky calendar year to the biopharma field, with a number of firms downsizing and restructuring their workforces to remain afloat. There are signs of recovery, as mergers and acquisitions picked up across the pharmaceutical and existence sciences market while in the latter Component of 2023 and possess https://sites.google.com/view/bio-sites/blog